Search research articles
Contact Us
Filters
Showing results (311-320 of 332) with videos related to
Page
of 34
Sort By:
Journal of Neurotrauma
|
March 15, 2016
Glucose-Dependent Insulinotropic Polypeptide Ameliorates Mild Traumatic Brain Injury-Induced Cognitive and Sensorimotor Deficits and Neuroinflammation in Rats
Yu-Wen Yu, Tsung-Hsun Hsieh, Kai-Yun Chen, et al.
Experimental Neurology
|
May 7, 2016
Corrigendum to "Combination therapy with lenalidomide and nanoceria ameliorates CNS autoimmunity", [Exp. Neurol. 273 (2015), 151-160]
Erez Eitan, Emmette R Hutchison, Nigel H Greig, et al.
Experimental Neurology
|
August 17, 2015
Combination therapy with lenalidomide and nanoceria ameliorates CNS autoimmunity
Erez Eitan, Emmette R Hutchison, Nigel H Greig, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
April 9, 2022
Microglia Drive Pockets of Neuroinflammation in Middle Age
Eric N Moca, Daniela Lecca, Keenan T Hope, et al.
CNS & Neurological Disorders Drug Targets
|
September 18, 2014
Protein misfolding and aggregation in Alzheimer's disease and type 2 diabetes mellitus
Ghulam M Ashraf, Nigel H Greig, Taqi A Khan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 24, 2009
GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism
Yazhou Li, TracyAnn Perry, Mark S Kindy, et al.
Lancet (London, England)
|
August 8, 2017
Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
Dilan Athauda, Kate Maclagan, Simon S Skene, et al.
Biorxiv : the Preprint Server for Biology
|
April 10, 2026
A new therapeutic approach for Parkinson's disease: dual targeting of α-Synuclein aggregation and microglial function by the novel immunomodulator 3-Monothiopomalidomide
Maria Francesca Palmas, Khosro Aminzadeh, Matteo Runfola, et al.
Cell Transplantation
|
May 17, 2019
Pomalidomide Reduces Ischemic Brain Injury in Rodents
Yan-Rou Tsai, David Tweedie, Ignacio Navas-Enamorado, et al.
ACS Pharmacology & Translational Science
|
April 16, 2021
Sustained Release GLP-1 Agonist PT320 Delays Disease Progression in a Mouse Model of Parkinson's Disease
Vicki Wang, Tung-Tai Kuo, Eagle Yi-Kung Huang, et al.
Page
of 34
Search research articles
Search
Showing results (311-320 of 332) with videos related to
Sort By:
Page
of 34
Journal of Neurotrauma
|
March 15, 2016
Glucose-Dependent Insulinotropic Polypeptide Ameliorates Mild Traumatic Brain Injury-Induced Cognitive and Sensorimotor Deficits and Neuroinflammation in Rats
Yu-Wen Yu, Tsung-Hsun Hsieh, Kai-Yun Chen, et al.
Experimental Neurology
|
May 7, 2016
Corrigendum to "Combination therapy with lenalidomide and nanoceria ameliorates CNS autoimmunity", [Exp. Neurol. 273 (2015), 151-160]
Erez Eitan, Emmette R Hutchison, Nigel H Greig, et al.
Experimental Neurology
|
August 17, 2015
Combination therapy with lenalidomide and nanoceria ameliorates CNS autoimmunity
Erez Eitan, Emmette R Hutchison, Nigel H Greig, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
April 9, 2022
Microglia Drive Pockets of Neuroinflammation in Middle Age
Eric N Moca, Daniela Lecca, Keenan T Hope, et al.
CNS & Neurological Disorders Drug Targets
|
September 18, 2014
Protein misfolding and aggregation in Alzheimer's disease and type 2 diabetes mellitus
Ghulam M Ashraf, Nigel H Greig, Taqi A Khan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 24, 2009
GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism
Yazhou Li, TracyAnn Perry, Mark S Kindy, et al.
Lancet (London, England)
|
August 8, 2017
Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
Dilan Athauda, Kate Maclagan, Simon S Skene, et al.
Biorxiv : the Preprint Server for Biology
|
April 10, 2026
A new therapeutic approach for Parkinson's disease: dual targeting of α-Synuclein aggregation and microglial function by the novel immunomodulator 3-Monothiopomalidomide
Maria Francesca Palmas, Khosro Aminzadeh, Matteo Runfola, et al.
Cell Transplantation
|
May 17, 2019
Pomalidomide Reduces Ischemic Brain Injury in Rodents
Yan-Rou Tsai, David Tweedie, Ignacio Navas-Enamorado, et al.
ACS Pharmacology & Translational Science
|
April 16, 2021
Sustained Release GLP-1 Agonist PT320 Delays Disease Progression in a Mouse Model of Parkinson's Disease
Vicki Wang, Tung-Tai Kuo, Eagle Yi-Kung Huang, et al.
Page
of 34